| Timothy Z Millican, APRN, CRNA | |
|
99 E River Dr, 5th Floor C/o Ipms, East Hartford, CT 06108-3288 | |
| (860) 282-0833 | |
| (860) 282-0170 |
| Full Name | Timothy Z Millican |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 23 Years |
| Location | 99 E River Dr, East Hartford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598724197 | NPI | - | NPPES |
| 004221834 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 002573 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Anesthesia Associates Llc | 1759281165 | 373 |
News Archive
A recent international observational study provides important data on the safety of head and neck cancer surgery during the COVID-19 pandemic.
Janssen-Cilag International NV today announced the early stopping of PCYC-1112-CA, the Phase 3 study of ibrutinib in the treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, based on the recommendation of an Independent Data Monitoring Committee, which concluded that the study showed a significant difference in progression-free survival as compared to the control, the primary endpoint of the study.
The joys of motherhood for many women can also lead other new moms to experience postpartum depression and even worse - ideas for committing suicide.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced the successful completion of a short-term safety, tolerability, and pharmacokinetic study of VK5211 in healthy elderly subjects. VK5211, the company's lead program for muscle and bone disorders, is an orally available, non-steroidal selective androgen receptor modulator (SARM) being developed for the treatment of patients recovering from non-elective hip fracture surgery.
Stem cell research laboratories at the University of California, Riverside, Loma Linda University and the California State University at San Bernardino have formed the "Inland Empire Stem Cell Consortium" to enhance collaboration among the three universities and bring focus to stem cell work being done in inland Southern California.
› Verified 5 days ago
| Entity Name | Integrated Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881636397 PECOS PAC ID: 1759281165 Enrollment ID: O20040112000163 |
News Archive
A recent international observational study provides important data on the safety of head and neck cancer surgery during the COVID-19 pandemic.
Janssen-Cilag International NV today announced the early stopping of PCYC-1112-CA, the Phase 3 study of ibrutinib in the treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, based on the recommendation of an Independent Data Monitoring Committee, which concluded that the study showed a significant difference in progression-free survival as compared to the control, the primary endpoint of the study.
The joys of motherhood for many women can also lead other new moms to experience postpartum depression and even worse - ideas for committing suicide.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced the successful completion of a short-term safety, tolerability, and pharmacokinetic study of VK5211 in healthy elderly subjects. VK5211, the company's lead program for muscle and bone disorders, is an orally available, non-steroidal selective androgen receptor modulator (SARM) being developed for the treatment of patients recovering from non-elective hip fracture surgery.
Stem cell research laboratories at the University of California, Riverside, Loma Linda University and the California State University at San Bernardino have formed the "Inland Empire Stem Cell Consortium" to enhance collaboration among the three universities and bring focus to stem cell work being done in inland Southern California.
› Verified 5 days ago
| Entity Name | Woodland Anesthesiology Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437109824 PECOS PAC ID: 8820083652 Enrollment ID: O20040420000027 |
News Archive
A recent international observational study provides important data on the safety of head and neck cancer surgery during the COVID-19 pandemic.
Janssen-Cilag International NV today announced the early stopping of PCYC-1112-CA, the Phase 3 study of ibrutinib in the treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, based on the recommendation of an Independent Data Monitoring Committee, which concluded that the study showed a significant difference in progression-free survival as compared to the control, the primary endpoint of the study.
The joys of motherhood for many women can also lead other new moms to experience postpartum depression and even worse - ideas for committing suicide.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced the successful completion of a short-term safety, tolerability, and pharmacokinetic study of VK5211 in healthy elderly subjects. VK5211, the company's lead program for muscle and bone disorders, is an orally available, non-steroidal selective androgen receptor modulator (SARM) being developed for the treatment of patients recovering from non-elective hip fracture surgery.
Stem cell research laboratories at the University of California, Riverside, Loma Linda University and the California State University at San Bernardino have formed the "Inland Empire Stem Cell Consortium" to enhance collaboration among the three universities and bring focus to stem cell work being done in inland Southern California.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy Z Millican, APRN, CRNA 99 E River Dr, 5th Floor C/o Ipms, East Hartford, CT 06108-3288 Ph: (860) 282-0833 | Timothy Z Millican, APRN, CRNA 99 E River Dr, 5th Floor C/o Ipms, East Hartford, CT 06108-3288 Ph: (860) 282-0833 |
News Archive
A recent international observational study provides important data on the safety of head and neck cancer surgery during the COVID-19 pandemic.
Janssen-Cilag International NV today announced the early stopping of PCYC-1112-CA, the Phase 3 study of ibrutinib in the treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, based on the recommendation of an Independent Data Monitoring Committee, which concluded that the study showed a significant difference in progression-free survival as compared to the control, the primary endpoint of the study.
The joys of motherhood for many women can also lead other new moms to experience postpartum depression and even worse - ideas for committing suicide.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders, today announced the successful completion of a short-term safety, tolerability, and pharmacokinetic study of VK5211 in healthy elderly subjects. VK5211, the company's lead program for muscle and bone disorders, is an orally available, non-steroidal selective androgen receptor modulator (SARM) being developed for the treatment of patients recovering from non-elective hip fracture surgery.
Stem cell research laboratories at the University of California, Riverside, Loma Linda University and the California State University at San Bernardino have formed the "Inland Empire Stem Cell Consortium" to enhance collaboration among the three universities and bring focus to stem cell work being done in inland Southern California.
› Verified 5 days ago
Ellen E Monforte, APRN, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 | |
Gail B Snyder, APRN, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 | |
Vincent G Brunelli, APRN CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 111 Founders Plz, 300 Co Ipms, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 | |
Holly D Simms, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 99 East River Drive, 5th Floor, East Hartford, CT 06108 Phone: 860-282-0833 Fax: 860-282-0170 | |
Ms. Heather Ann Portereiko, CRNA, APRN Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 99 E River Dr, 5th Floor, East Hartford, CT 06108 Phone: 860-282-4133 Fax: 860-289-0746 | |
Vanassa J Sebastian, APRN, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 | |
Elizabeth A Anderson, APRN, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 111 Founders Plz, #300 C/o Ipms, East Hartford, CT 06108 Phone: 860-282-4137 Fax: 860-282-0170 |